Disease, Disability, and Injury Prevention and Control Special Emphasis Panels (SEP): In-Country Development of H5N1 Influenza Vaccines in Vietnam, Program Announcement Number CI06-008, 935 [06-98]

Download as PDF cprice-sewell on PROD1PC66 with NOTICES Federal Register / Vol. 71, No. 4 / Friday, January 6, 2006 / Notices by section 1014 of the Medicare Modernization Act. DATES: The business meeting of the Working Group will be held on Wednesday, January 18, 2006, from 9 a.m. to 4:30 p.m. and Thursday, January 19, 2006 from 9 a.m. to 2 p.m. ADDRESSES: The meeting will take place in the conference room of the United Food and Commercial Workers International Union, in Washington, DC. The office is located at 1775 K Street NW. The main receptionist area is located on the 7th floor; the conference room is located on the 11th floor. The meeting is open to the public. FOR FURTHER INFORMATION CONTACT: Caroline Taplin, Citizens’ Health Care Working Group, at (301) 443–1514 or ctaplin@ahrq.gov. If sign language interpretation or other reasonable accommodation for a disability is needed, please contact Mr. Donald L. Inniss, Director, Office of Equal Employment Opportunity Program, Program Support Center, on (301) 443– 1144. The agenda for this Working Group meeting will be available on the Citizens’ Working Group Web site, www.citizenshealthcare.gov. Also available at that site is a roster of Working Group members. When summaries of the meeting are completed, they will also be available on the Web site. SUPPLEMENTARY INFORMATION: Section 1014 of Pub. L. 108–173, (known as the Medicare Modernization Act) directs the Secretary of the Department of Health and Human Servcies (DHHS), acting through the Agency for Healthcare Research and Quality, to establish a Citizens’ Health Care Working Group (Citien Group). This statutory provision, codified at 42 U.S.C. 299 n., directs the Working Group to: (1) Identify options for changing our health care system so that every American has the ability to obtain quality, affordable health care coverage; (2) provide for a nationwide public debate about improving the health care system; and (3) submit its recommendations to the President and the Congress. The Citizens’ Health Care Working Group is composed of 15 members: the Secretary of DHHS is designated as a member by statute and the Comptroller General of the U.S. Government Accountability Office (GAO) was directed to name the remaining 14 members whose appointments were announced on February 28, 2005. Working Group Meeting Agenda The Working Group business meeting on January 18th and 19th will be VerDate Aug<31>2005 15:23 Jan 05, 2006 Jkt 208001 devoted to ongoing Working Group business. Topics to be addressed are expected to include: an update on community meetings; background information on public perceptions on health care quality and efficiency; discussion of data from various sources including community meetings, Web site questions, Web casts, the citizen survey and other sources of public input; and broad concepts relating to the Working Group’s recommendation report. Submission of Written Information The Working Group invites written submissions on those topics to be addressed at the Working Group business meetings listed above. In general, individuals or organizations wishing to provide written information for consideration by the Citizens’ Health Care Working Group should submit information electronically to citizenshealth@ahrq.gov. Since all electronic submissions will be posted on the Working Group Web site, separate submissions by topic will facilitate review of ideas submitted on each topic by the Working Group and the public. This notice is published less than 15 days in advance of the meeting due to logistical difficulties. Dated: December 30, 2005. Carolyn M. Clancy, Director. [FR Doc. 06–91 Filed 1–5–06; 8:45 am] BILLING CODE 4160–90–M Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panels (SEP): In-Country Development of H5N1 Influenza Vaccines in Vietnam, Program Announcement Number CI06–008 In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the following meeting: Name: Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): In-Country Development of H5N1 Influenza Vaccines in Vietnam, Program Announcement Number CI06–008. Times and Dates: 11 a.m.–1 p.m., January 23, 2006 (Closed). Place: Teleconference. Frm 00032 Fmt 4703 Status: The meeting will be closed to the public in accordance with provisions set forth in section 5523b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92– 463. Matters to be Discussed: The meeting will include the review, discussion, and evaluation of applications received in response to: In-Country Development of H5N1 Influenza Vaccines in Vietnam, Program Announcement Number CI06– 008. FOR FURTHER INFORMATION CONTACT: Mary Lerchen, Dr.P.H., Associate Director, Office of Public Health Research, Centers for Disease Control and Prevention, 1600 Clifton Road, NE., Mailstop D–72, Atlanta, GA 30030, Telephone (404) 639–4897. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: December 30, 2005. Alvin Hall, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 06–98 Filed 1–5–06; 8:45 am] BILLING CODE 4163–18–M DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES PO 00000 935 Sfmt 4703 Centers for Medicare & Medicaid Services [Document Identifier: CMS–R–250] Agency Information Collection Activities: Proposed Collection; Comment Request Centers for Medicare & Medicaid Services. In compliance with the requirement of section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995, the Centers for Medicare & Medicaid Services (CMS) is publishing the following summary of proposed collections for public comment. Interested persons are invited to send comments regarding this burden estimate or any other aspect of this collection of information, including any of the following subjects: (1) The necessity and utility of the proposed information collection for the proper performance of the agency’s functions; (2) the accuracy of the estimated AGENCY: E:\FR\FM\06JAN1.SGM 06JAN1

Agencies

[Federal Register Volume 71, Number 4 (Friday, January 6, 2006)]
[Notices]
[Page 935]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 06-98]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panels (SEP): In-Country Development of H5N1 Influenza 
Vaccines in Vietnam, Program Announcement Number CI06-008

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following meeting:
    Name: Disease, Disability, and Injury Prevention and Control 
Special Emphasis Panel (SEP): In-Country Development of H5N1 Influenza 
Vaccines in Vietnam, Program Announcement Number CI06-008.
    Times and Dates: 11 a.m.-1 p.m., January 23, 2006 (Closed).
    Place: Teleconference.
    Status: The meeting will be closed to the public in accordance with 
provisions set forth in section 5523b(c)(4) and (6), Title 5 U.S.C., 
and the Determination of the Director, Management Analysis and Services 
Office, CDC, pursuant to Public Law 92-463.
    Matters to be Discussed: The meeting will include the review, 
discussion, and evaluation of applications received in response to: In-
Country Development of H5N1 Influenza Vaccines in Vietnam, Program 
Announcement Number CI06-008.

FOR FURTHER INFORMATION CONTACT: Mary Lerchen, Dr.P.H., Associate 
Director, Office of Public Health Research, Centers for Disease Control 
and Prevention, 1600 Clifton Road, NE., Mailstop D-72, Atlanta, GA 
30030, Telephone (404) 639-4897.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both CDC and the Agency for Toxic Substances and Disease Registry.

    Dated: December 30, 2005.
Alvin Hall,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 06-98 Filed 1-5-06; 8:45 am]
BILLING CODE 4163-18-M
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.